Federal grants to Circumvent Pharmaceuticals Inc.
Circumvent Pharmaceuticals Inc. in Portland, Oregon received $4.9 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Extramural Research Programs in the Neurosciences and Neurological Disorders, with $4.1 million. In fiscal 2025 it was awarded $1.2 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$4.9 million
- Awards3
- Awarded in FY 2025$1.2 million
- Largest award$4.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $2.3 million |
| FY 2022 | 1 | $1.4 million |
| FY 2023 | 0 | $0 |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $1.2 million |
Programs that fund Circumvent Pharmaceuticals Inc.
| Program | Awards | Amount |
|---|---|---|
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $4.1 million |
| Aging Research | 1 | $507,284 |
| Child Health and Human Development Extramural Research | 1 | $304,787 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $4.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of n-tert-(BUTYL)hydroxylamine (NTBUHA) as a therapeutic agent for treating infantile neuronal ceroid lipofuscinosis (INCL) - project summary/abstract a significant unmet medical need exists for a therapy to treat patients with infantile neuronal ceroid lipofuscinosis (incl, or CLN1 batt | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 17, 2021 | $4.1 million |
| Alzheimer's disease: simultaneous modulation of nmdar, BACE1, app and fyn activity by palmitoylation-targeting CIRC825 - project summary/abstract alzheimer’s disease (AD) has predominantly been characterized by amyloid plaques and neurofibrillary tau tangles, and soluble oligomers of these peptides | Aging Research | July 13, 2021 | $507,284 |
| Development of a protein palmitoylation assay to monitor treatment of CLN1 batten disease - summary in the specific aims outlined by the following proposal for an NIH sbir phase 1 project, we will use a multi-faceted approach to identify key substrates for targeted assay development to monitor thera | Child Health and Human Development Extramural Research | September 3, 2021 | $304,787 |
Questions people ask
How much federal grant money does Circumvent Pharmaceuticals Inc. get?
$4.9 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Circumvent Pharmaceuticals Inc. the most?
The Department of Health and Human Services, with $4.9 million in 3 awards.
What is Circumvent Pharmaceuticals Inc.'s largest federal grant?
$4.1 million under Extramural Research Programs in the Neurosciences and Neurological Disorders, with its first action in the period on September 17, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Circumvent Pharmaceuticals Inc.?
Its largest are Extramural Research Programs in the Neurosciences and Neurological Disorders, Aging Research and Child Health and Human Development Extramural Research.
Other grant recipients in Portland
- Oregon Health & Science University
- Tri-County Metropolitan Transportation District of Oregon
- Oregon Department of Housing & Community Services
- Mercy Corps
- Pacific States Marine Fisheries Commission
- Oregon Department of Environmental Quality
- Port of Portland
- Portland State University
Largest federal grant recipients in Oregon · Federal grants in Oregon